- First New Schizophrenia Treatment Approach In Decades Gets FDA Approval IFLScience
- Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug CNBC
- F.D.A. Approves the First New Schizophrenia Drug in Decades The New York Times
- Revolutionary drug for schizophrenia wins US approval Nature.com
- FDA approves a novel drug for schizophrenia, a potential ‘game changer’ The Washington Post
Discussion about this post